Pardes Biosciences
Pardes, a MediPacific company, is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19.

Year Established: 2020
Stock Ticker: PRDS
Exchange: NASDAQ